Clinical Evaluation of Phenserine Tartrate Controlled-Release Tablet

Department
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH NIDA
Country
United States
Closing Date
Not specified
Estimated Value
Not disclosed

Summary

The National Institutes of Health (NIDA) is extending the ordering period for the clinical evaluation of a phenserine tartrate extended controlled-release tablet. The work covers pharmaceutical clinical study and research support under NAICS 541990. No set-aside applies.

Full Description

https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=8b940498fba8401480c47994bf46c4c6

Get the next pharmaceuticals tenders in your inbox tomorrow morning. Free.

Who won similar contracts

Recent government contract awards from the same buyer or for similar work. Public records from open.canada.ca, SAM.gov, and USAspending.gov.

A similar contract went to MRIGLOBAL for $5,000,000 in 2026.

HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH NIDAAN11

A similar contract went to CURIA GLOBAL INC for $49,999,999 in 2026.

HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH NIDAAN11

A similar contract went to ALCHEM LABORATORIES CORPORATION for $49,999,999 in 2026.

HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH NIDAAN11

A similar contract went to SRI INTERNATIONAL for $49,999,999 in 2026.

HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH NIDAAN11

Browse all recent awards →

Similar Tenders